June 24-26 , the 23rd China International Pharmaceutical Ingredients Exhibition （ CPHI China 2025 ）The Shanghai New International Expo Center （Pudong） grand opening. Bontac, as one of the exhibitors, gathered together with experts, scholars, bio-manufacturing enterprises and customer representatives from all over the world to discuss the frontier trends, technical challenges and cooperation opportunities of the synthetic biology industry and work together to promote the continuous innovation and development of the industry.
PART 01
Core materials demonstrate technical strength
During the exhibition, The blockbuster was on display. A variety of core feedstocks, including NMN, reduced NMN (NMNH), NAD, NADH and NRHM, This fully demonstrates. Company Key Nodes in NAD + Metabolic Pathway Deep R & D accumulation With mature industrialization capability .
PART 02
Natural new products lead the health trend
At the same time, Bontac has launched a new natural sweetener - stevioside Reb-M / Reb-D. The product is derived from stevia, produced by a full enzymatic process, with significant advantages such as high sweetness, low calorie and taste close to sucrose. It is the most attractive sugar substitute solution in the current market .
In the field of natural products raw materials, Bontac focused on the rare ginsenoside Rh2 and Rg3 Rg3 . These raw materials not only meet the strong demand of the international market for healthy diet, more to meet global brand customers high-standard , high-quality raw materials strict requirements .
During the exhibition, BOTAC team showed its innovative raw materials and technical strength to the global health industry colleagues with full enthusiasm and rich professional knowledge。The atmosphere of the booth was warm, and its innovative raw materials and solutions won wide recognition and praise from domestic and foreign visitors.
PART 03
Forward-looking layout and global journey
The market potential of NAD ⁺-related raw materials is becoming increasingly prominent with the continuous rise in attention to global anti-aging and metabolic health . Bontac will continue to deepen the research on NAD ⁺ metabolism mechanism and raw material innovation , focusing on key directions such as reduced coenzyme , crystal engineering and bioavailability improvement , accelerating the frontier scientific research results Industrialization transformation .
Looking ahead, Bontac will accelerate the international market layout , deepen the strategic cooperation with global scientific research institutions and brand partners，We are committed to building a complete closed-loop industrial ecology from basic research to end products, providing more efficient, safe and reliable raw material solutions for the global health industry, and helping global consumers achieve a better vision of a healthier and longer life.
The exhibition is not the end, but the starting point of a new journey。In October 2025, Bontai Biotech will continue to appear on the global professional stage :
October 15, Japan Natural Food Raw Materials Exhibition (Humi Exhibition Hall, Tokyo)
CPHI Europe (convention and exhibition center in Frankfurt, Germany)
October 29, American Natural Extracts and Health Raw Materials Show (Mandalay Bay Convention Center, Las Vegas)
Bontac will continue to explore vigorously in the field of synthetic biology to continue to create innovative value for the global health industry.
About Bontac
Bontac Engineering (Shenzhen) Ltd. Founded in July 2012, is a national high-tech enterprise with synthetic biology technologies such as bioenzyme catalysis as its core, integrating research and development, production and sales. The company's main products involve six series of products such as coenzyme series, natural products series, sugar substitute series, cosmetics series, dietary supplement series, and pharmaceutical intermediate series.
NMN Industry Pioneers
The number of NMN patents in the world
The world's first to achieve mass production of NMN and NMNH
Global pioneer of whole enzyme technology
Industry leaders in the coenzyme series product segment
The first domestic mass production of rare ginsenosideRh2 /Rg3
The country's first and only provincial coenzyme engineering technology research center in Guangdong Province
